Gerostate Alpha went through Y Combinator in the Summer 2018 batch, describing itself as Developing novel therapeutics for aging and chronic disease. Y Combinator's company directory lists it as Inactive. The directory does not say why a company stopped, and this page does not guess.
- Batch
- Summer 2018
- What they did
- Developing novel therapeutics for aging and chronic disease
- Industry
- Healthcare
- Team size
- 6
- Based
- San Francisco, CA, USA; Novato, CA, USA
- Status
- Inactive, as listed by Y Combinator
Its batch
Summer 2018 had 131 companies in YC's listing: 77 Active, 21 Acquired, 1 Public and 32 Inactive, so Gerostate Alpha is one of 32 companies from that batch listed as Inactive (24%). Across YC batches at least two years old, 23% of companies are listed Inactive.
Statuses are Y Combinator's own listing in its public company directory, read on the date shown. YC's directory can drop companies altogether, so the Inactive counts here are a floor, not a full count of companies that stopped. Acquired and Public are as YC lists them; neither says anything about the price or the outcome for founders.
The record: Gerostate Alpha in the Y Combinator directory. Measured 2026-09-26 from Y Combinator's company directory.
YC Summer 2018All shut-down YC companiesYC outcomes
Tools for this story
Each opens in a new tab, filled in for Gerostate Alpha. With no account yet, you sign up free and land on the result.